These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24989076)

  • 21. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.
    Johnson-Tesch BA; Gawande RS; Zhang L; MacMillan ML; Nascene DR
    Pediatr Radiol; 2017 Jun; 47(7):868-876. PubMed ID: 28283722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
    Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
    DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two common founder mutations of the fanconi anemia group G gene FANCG/XRCC9 in the Japanese population.
    Yagasaki H; Oda T; Adachi D; Nakajima T; Nakahata T; Asano S; Yamashita T
    Hum Mutat; 2003 May; 21(5):555. PubMed ID: 12673805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Genetic Features of Patients With Fanconi Anemia in Lebanon and Report on Novel Mutations in the FANCA and FANCG Genes.
    Farah RA; Nair P; Koueik J; Yammine T; Khalifeh H; Korban R; Collet A; Khayat C; Dubois-Denghien C; Chouery E; Blanluet M; El-Hayek S; Stoppa-Lyonnet D; Megarbane A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e727-e735. PubMed ID: 32947577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
    Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
    Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer and Fanconi anemia: what are the connections?
    Zdzienicka MZ; Arwert F
    Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
    Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
    Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of FANCA mutations in Greek patients.
    Selenti N; Sofocleous C; Kattamis A; Kolialexi A; Kitsiou S; Fryssira E; Polychronopoulou S; Kanavakis E; Mavrou A
    Anticancer Res; 2013 Aug; 33(8):3369-74. PubMed ID: 23898106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases.
    Bakker JL; van Mil SE; Crossan G; Sabbaghian N; De Leeneer K; Poppe B; Adank M; Gille H; Verheul H; Meijers-Heijboer H; de Winter JP; Claes K; Tischkowitz M; Waisfisz Q
    Hum Mutat; 2013 Jan; 34(1):70-3. PubMed ID: 22911665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
    Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling Fanconi Anemia Gene Mutations among Iranian Patients.
    Esmail Nia G; Fadaee M; Royer R; Najmabadi H; Akbari MR
    Arch Iran Med; 2016 Apr; 19(4):236-40. PubMed ID: 27041517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Founder haplotype analysis of Fanconi anemia in the Korean population finds common ancestral haplotypes for a FANCG variant.
    Park J; Kim M; Jang W; Chae H; Kim Y; Chung NG; Lee JW; Cho B; Jeong DC; Park IY; Park MS
    Ann Hum Genet; 2015 May; 79(3):153-61. PubMed ID: 25703136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.
    Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD
    J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.
    Solyom S; Winqvist R; Nikkilä J; Rapakko K; Hirvikoski P; Kokkonen H; Pylkäs K
    Cancer Lett; 2011 Mar; 302(2):113-8. PubMed ID: 21236561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
    Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
    Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.
    Vuorela M; Pylkäs K; Hartikainen JM; Sundfeldt K; Lindblom A; von Wachenfeldt Wäppling A; Haanpää M; Puistola U; Rosengren A; Anttila M; Kosma VM; Mannermaa A; Winqvist R
    Breast Cancer Res Treat; 2011 Dec; 130(3):1003-10. PubMed ID: 21750962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.